Literature DB >> 23983213

New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant.

Swantje Liedmann1, Eike R Hrincius, Darisuren Anhlan, Jonathan A McCullers, Stephan Ludwig, Christina Ehrhardt.   

Abstract

The identification of amino acid motifs responsible for increased virulence and/or transmission of influenza viruses is of enormous importance to predict pathogenicity of upcoming influenza strains. We phenotypically and genotypically compared 2 variants of influenza virus A/PR/8/34 with different passage histories. The analysis revealed differences in virulence due to an altered type I interferon (IFN) induction, as evidenced by experiments using IFNAR(-/-) mice. Interestingly, these differences were not due to altered functions of the well-known viral IFN antagonists NS1 or PB1-F2. Using reassortant viruses, we showed that differences in the polymerase proteins and nucleoprotein determined the altered virulence. In particular, changes in PB1 and PA contributed to an altered host type I IFN response, indicating IFN antagonistic properties of these proteins. Thus, PB1 and PA appear to harbor previously unknown virulence markers, which may prove helpful in assessing the risk potential of emerging influenza viruses.

Entities:  

Keywords:  influenza A virus; polymerase complex; type I interferon; virulence; virulence determinants

Mesh:

Substances:

Year:  2013        PMID: 23983213     DOI: 10.1093/infdis/jit463

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Crucial role of PA in virus life cycle and host adaptation of influenza A virus.

Authors:  Jiao Hu; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2014-07-29       Impact factor: 3.402

2.  Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.

Authors:  Danyel Evseev; Domingo Miranzo-Navarro; Ximena Fleming-Canepa; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

Review 3.  Molecular determinants of influenza virus pathogenesis in mice.

Authors:  Ram P Kamal; Jaqueline M Katz; Ian A York
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background.

Authors:  Dai-Lun Shin; Bastian Hatesuer; Silke Bergmann; Tatiana Nedelko; Klaus Schughart
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.

Authors:  Young J Lee; Jeong Y Lee; Yo H Jang; Sang-Uk Seo; Jun Chang; Baik L Seong
Journal:  Front Microbiol       Date:  2018-01-31       Impact factor: 5.640

6.  A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.

Authors:  Ben X Wang; Lianhu Wei; Lakshmi P Kotra; Earl G Brown; Eleanor N Fish
Journal:  Viruses       Date:  2017-05-12       Impact factor: 5.048

7.  Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.

Authors:  Julie McAuley; Yi-Mo Deng; Brad Gilbertson; Charley Mackenzie-Kludas; Ian Barr; Lorena Brown
Journal:  Virol J       Date:  2017-08-22       Impact factor: 4.099

8.  Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions.

Authors:  Swantje Liedmann; Eike R Hrincius; Cliff Guy; Darisuren Anhlan; Rüdiger Dierkes; Robert Carter; Gang Wu; Peter Staeheli; Douglas R Green; Thorsten Wolff; Jonathan A McCullers; Stephan Ludwig; Christina Ehrhardt
Journal:  Nat Commun       Date:  2014-12-09       Impact factor: 14.919

9.  Cellular changes in blood indicate severe respiratory disease during influenza infections in mice.

Authors:  Leonie Dengler; Nora Kühn; Dai-Lun Shin; Bastian Hatesuer; Klaus Schughart; Esther Wilk
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

10.  The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections.

Authors:  Janine J Wilden; Andre van Krüchten; Lutz Gieselmann; Eike R Hrincius; Stefanie Deinhardt-Emmer; Karoline F Haupt; Hannah F Preugschas; Silke Niemann; Stephan Ludwig; Christina Ehrhardt
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.